From Big Data to Smart Data for Pharmacovigilance: The Role of Healthcare Databases and Other Emerging Sources Gianluca TrifiròJanet SultanaAndrew Bate Current Opinion 24 August 2017 Pages: 143 - 149
Overview of Pharmacovigilance System in Vietnam: Lessons Learned in a Resource-Restricted Country Khac-Dung NguyenPhuong-Thuy NguyenSten Olsson Leading Article 03 October 2017 Pages: 151 - 159
Use of Antihypertensive Drugs and Risk of Malignant Melanoma: A Meta-analysis of Observational Studies Huilin TangShuangshuang FuJiali Han Systematic Review 13 September 2017 Pages: 161 - 169
Safety of Russian-Backbone Trivalent, Live Attenuated Seasonal Influenza Vaccine in Healthy Subjects: Open-Label, Non-randomized Phase 4 Study Prashant V. NigwekarAnuj KumarPrasad S. Kulkarni short communication 12 October 2017 Pages: 171 - 177
Preferences of Patients and Pharmacists with Regard to the Management of Drug–Drug Interactions: A Choice-Based Conjoint Analysis Mette HeringaAnnemieke Floor-SchreuderingMarcel L. Bouvy Original Research Article Open access 30 September 2017 Pages: 179 - 189
Study Design and Evaluation of Risk Minimization Measures: A Review of Studies Submitted to the European Medicines Agency for Cardiovascular, Endocrinology, and Metabolic Drugs Giampiero MazzagliaSabine M. J. StrausEnrica Alteri Original Research Article Open access 09 November 2017 Pages: 191 - 202
Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre Sarah WatsonRebecca E. ChandlerFlorence van Hunsel Original Research Article Open access 20 September 2017 Pages: 203 - 212
All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population Alyssa M. PeckhamKathleen A. FairmanDavid A. Sclar Original Research Article 27 September 2017 Pages: 213 - 228
Erlotinib Plus Bevacizumab Phase ll Study in Patients with Advanced Non-small-Cell Lung Cancer (JO25567): Updated Safety Results Terufumi KatoTakashi SetoNobuyuki Yamamoto Original Research Article Open access 17 October 2017 Pages: 229 - 237